Jasper Therapeutics, Inc. (JSPR): Form 8-K/A filed 2026-10-01
- Accepted by EDGAR
- 2026-10-01 17:29 ET
- Event date
- 2026-07-16
- Accession no.
- 0001213900-26-105924
- Original filing
- SEC EDGAR filing index
Items reported
- Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K/A | AMENDMENT NO. 1 TO FORM 8-K | ea0306860-8ka1_jasper.htm |
| EX-23.1 | CONSENT OF EISNERAMPER LLP, INDEPENDENT AUDITORS OF KIRA PHARMACEUTICALS | ea030686001ex23-1.htm |
| EX-99.1 | AUDITED FINANCIAL STATEMENTS OF KIRA PHARMACEUTICALS AS OF DECEMBER 31, 2025 AND | ea030686001ex99-1.htm |
| EX-99.2 | UNAUDITED FINANCIAL STATEMENTS OF KIRA PHARMACEUTICALS AS OF JUNE 30, 2026 AND F | ea030686001ex99-2.htm |
| EX-99.3 | UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF JASPER THERAPEUT | ea030686001ex99-3.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.